Drug
10 Dose OF E5501
10 Dose OF E5501: highest development phase Phase 1, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| 10-mg dose of E5501 2G tablet NCT01549054 | Phase 1 | Idiopathic Thrombocytopenic Purpura |
Latest
No recent events.
Follow 10 Dose OF E5501 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.